DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,053 filers reported holding DANAHER CORPORATION in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $210,201 | -5.0% | 834 | 0.0% | 0.08% | -9.9% |
Q4 2022 | $221,360 | -6.2% | 834 | -8.7% | 0.09% | -18.0% |
Q3 2022 | $236,000 | 0.0% | 913 | -1.7% | 0.11% | +7.8% |
Q2 2022 | $236,000 | -22.4% | 929 | -10.2% | 0.10% | -8.0% |
Q1 2022 | $304,000 | -33.5% | 1,035 | -25.4% | 0.11% | -31.7% |
Q4 2021 | $457,000 | +0.7% | 1,388 | -6.9% | 0.16% | -5.7% |
Q3 2021 | $454,000 | +13.5% | 1,491 | 0.0% | 0.17% | +16.0% |
Q2 2021 | $400,000 | +14.3% | 1,491 | -4.1% | 0.15% | +7.9% |
Q1 2021 | $350,000 | -12.5% | 1,554 | -13.7% | 0.14% | -21.0% |
Q4 2020 | $400,000 | +3.1% | 1,801 | 0.0% | 0.18% | -15.0% |
Q3 2020 | $388,000 | +11.2% | 1,801 | -8.8% | 0.21% | +21.8% |
Q2 2020 | $349,000 | +12.6% | 1,974 | -11.8% | 0.17% | -12.8% |
Q1 2020 | $310,000 | -14.6% | 2,238 | -5.4% | 0.20% | +7.1% |
Q4 2019 | $363,000 | +5.5% | 2,366 | -0.6% | 0.18% | -3.2% |
Q3 2019 | $344,000 | +0.6% | 2,381 | -0.4% | 0.19% | -1.1% |
Q2 2019 | $342,000 | +6.5% | 2,391 | -1.5% | 0.19% | +6.1% |
Q1 2019 | $321,000 | +21.1% | 2,428 | -5.6% | 0.18% | -3.2% |
Q4 2018 | $265,000 | -13.7% | 2,573 | -8.9% | 0.18% | -11.5% |
Q3 2018 | $307,000 | -6.1% | 2,823 | -14.7% | 0.21% | -9.9% |
Q2 2018 | $327,000 | +0.9% | 3,311 | 0.0% | 0.23% | -3.7% |
Q1 2018 | $324,000 | -28.2% | 3,311 | -31.9% | 0.24% | -24.9% |
Q4 2017 | $451,000 | +8.2% | 4,860 | -0.1% | 0.32% | +0.9% |
Q3 2017 | $417,000 | +1.0% | 4,865 | -0.7% | 0.32% | -2.2% |
Q2 2017 | $413,000 | 0.0% | 4,898 | +1.4% | 0.32% | -2.4% |
Q1 2017 | $413,000 | -33.8% | 4,830 | -39.8% | 0.33% | -29.4% |
Q4 2016 | $624,000 | -59.0% | 8,019 | -58.7% | 0.47% | -60.5% |
Q3 2016 | $1,523,000 | -17.5% | 19,432 | +6.4% | 1.19% | -17.1% |
Q2 2016 | $1,845,000 | +3.7% | 18,266 | -2.6% | 1.44% | +2.5% |
Q1 2016 | $1,780,000 | -27.6% | 18,763 | -29.1% | 1.40% | -29.9% |
Q4 2015 | $2,458,000 | +6.6% | 26,467 | -2.2% | 2.00% | +11.2% |
Q3 2015 | $2,305,000 | -9.8% | 27,056 | -9.4% | 1.80% | -8.9% |
Q2 2015 | $2,556,000 | +1.6% | 29,863 | +0.8% | 1.98% | +3.9% |
Q1 2015 | $2,515,000 | +2.4% | 29,623 | +3.4% | 1.90% | +2.8% |
Q4 2014 | $2,455,000 | +53.3% | 28,647 | +35.9% | 1.85% | +43.1% |
Q3 2014 | $1,601,000 | -3.7% | 21,076 | -0.2% | 1.30% | -3.1% |
Q2 2014 | $1,663,000 | +5.2% | 21,124 | +0.2% | 1.34% | +8.3% |
Q1 2014 | $1,581,000 | -2.7% | 21,084 | +0.2% | 1.24% | +0.1% |
Q4 2013 | $1,625,000 | +9.1% | 21,044 | -2.1% | 1.23% | +2.2% |
Q3 2013 | $1,490,000 | +8.3% | 21,495 | -1.1% | 1.21% | +5.4% |
Q2 2013 | $1,376,000 | – | 21,731 | – | 1.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |